Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WellSpring Invests $3M, Enters IDT Australia Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

WellSpring Invests $3M, Enters IDT Australia Pact

Adds capabilities and equipment; will produce several products for U.S. market

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WellSpring Pharma Services has completed a $3 million capital investment in new equipment and has entered a strategic partnership with IDT Australia Ltd. to manufacture drugs for the U.S. market.
 
The investment adds capabilities in smaller development-scale equipment, expanded manufacturing for specialized dosage forms, such as bilayer tablets, and improved support for high-potency compound manufacturing. New equipment includes: an Alexanderwerk Roller Compactor; an IMA Precisa capsule weight checker; a 400 kg O’Hara Tray Drying oven; a Korsch XL 400 Tablet Press with bilayer module; a Glatt GPCG 2/5 Fluid Bed Processor; an O’Hara Aqueous Film Coater with 18” and 30” interchangeable pans; and a 5L Becomix Counter sweep vessel.

Additionally, WellSpring signed a manufacturing and supply agreement to produce several products for IDT Australia at its facility near Toronto, including Pindolol, a cardiac drug with an estimated U.S. market value of $10 million.
 
“Our expanded capabilities include new expertise in process development and manufacturing for earlier phased clinical trials as well as future expansion of our large-scale manufacturing capabilities,” said David Mayers, president, WellSpring Pharma Services. “We’re now better equipped to offer our clients services from small-scale development and scale-up to large-scale manufacturing, packaging and distribution.”
 
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics